Medication-info.com Search Menu

Evkeeza (Evinacumab): Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
150 mg/mL
Active ingredient:

Patient information: uses, side effects, how to take - Evkeeza

What is EVKEEZA?

EVKEEZA is an injectable prescription medicine used along with diet and exercise and other low-density lipoprotein cholesterol (LDL-C) lowering medicines to lower LDL-C in adults and children 1 year of age and older with a type of high cholesterol called homozygous familial hypercholesterolemia (HoFH).

It is not known if EVKEEZA is safe and effective in children under 1 year of age.

Who should not use EVKEEZA?

Do not use EVKEEZA if you are allergic to evinacumab-dgnb or to any of the ingredients in EVKEEZA. See the end of this leaflet for a complete list of ingredients in EVKEEZA.

Before receiving EVKEEZA, tell your healthcare provider about all of your medical conditions, including if you:

  • are pregnant or plan to become pregnant. EVKEEZA may harm your unborn baby. Tell your healthcare provider if you become pregnant while using EVKEEZA. People who are able to become pregnant:

    • Your healthcare provider may do a pregnancy test before you start treatment with EVKEEZA.
    • You should use an effective method of birth control during treatment and for at least 5 months after the last dose of EVKEEZA. Talk with your healthcare provider about birth control methods that you can use during this time.
  • are breastfeeding or plan to breastfeed. It is not known if EVKEEZA passes into your breast milk. You and your healthcare provider should decide if you will receive EVKEEZA or breastfeed.

Tell your healthcare provider about all of the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

How will I receive EVKEEZA?

  • Your healthcare provider will give you EVKEEZA into your veins through an intravenous (IV) line over 60 minutes.
  • EVKEEZA should be given every month (4 weeks).
  • If you miss any infusion appointments, call your healthcare provider as soon as possible to reschedule.
  • Your healthcare provider may slow down your infusion rate, temporarily stop, or permanently stop treatment with EVKEEZA if you have certain side effects. See "What are the possible side effects of EVKEEZA?"
  • Your healthcare provider may prescribe other cholesterol-lowering medicines, to use with EVKEEZA. Use the other prescribed medicines exactly as your healthcare provider tells you to.

What are the possible side effects of EVKEEZA?

EVKEEZA can cause serious side effects, including:

  • Allergic reactions (hypersensitivity), including a severe reaction known as anaphylaxis. Tell your healthcare provider right away if you get any of the following symptoms:
  • swelling – mainly of the lips, tongue or throat which makes it difficult to swallow or breathe
  • breathing problems or wheezing
  • feeling dizzy or fainting
  • rash, hives
  • itching

The most common side effects of EVKEEZA include:

  • symptoms of the common cold
  • flu like symptoms
  • dizziness
  • runny nose
  • nausea
  • feeling tired or weak

Tell your healthcare provider if you have any side effect that bothers you or that does not go away.

These are not all of the possible side effects of EVKEEZA.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

General information about the safe and effective use of EVKEEZA.

Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. If you would like more information about EVKEEZA, talk with your healthcare provider. You can ask your healthcare provider for information about EVKEEZA that is written for health professionals.

What are the ingredients in EVKEEZA?

Active ingredient: evinacumab-dgnb

Inactive ingredients: L-arginine hydrochloride, L-histidine, L-histidine monohydrochloride monohydrate, L-proline, polysorbate 80, and Water for Injection, USP.

Manufactured by:

Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown, NY 10591-6707 U.S. License No. 1760

©2025 Regeneron Pharmaceuticals, Inc. All rights reserved.

For more information about EVKEEZA, go to www.EVKEEZA.com or call 1-833-EVKEEZA (833-385-3392)

About this document

Source: FDA drug labeling via NLM DailyMed · Application number: BLA 761181 · View the label on DailyMed

Revision date stated in the text: September 2025

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Evkeeza

Rx or OTC
Prescription (Rx)?
  • This drug is available only with a prescription from a licensed healthcare provider.
  • Rx
Drug class Angiopoietin-like 3 Inhibitor
Active ingredient Evinacumab 150 mg/mL
Dosage form Injection, solution, concentrate
Route Intravenous
Marketing status not in the current FDA NDC Directory
Company (applicant) REGENERON PHARMACEUTICALS
FDA approval BLA 761181Biologics License Application (BLA) Approved February 11, 2021
Manufacturers 1 labelers list this drug on DailyMed
Packages (NDC)
Package
150 mg/mL – 2.3 ml in 1 vial, single-use / 1 in 1 carton NDC 61755-013-01
150 mg/mL – 8 ml in 1 vial, single-use / 1 in 1 carton NDC 61755-010-01

Source: FDA drug labeling via NLM DailyMed, data as of October 31, 2026. FDA data (DailyMed, Orange Book, Drug Shortages, enforcement reports). Not a substitute for the advice of a doctor or pharmacist.